{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:31:13Z","timestamp":1794328273881,"version":"4.9.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The parkin-interacting substrate (PARIS, also known as ZNF746) is a transcriptional repressor, whose accumulation and phosphorylation play central pathological roles in Parkinson\u2019s disease (PD). PARIS-induced transcriptional repression of PGC-1\u03b1 or MDM4 contributes to mitochondrial dysfunction and p53-dependent neuron loss in PD. Despite the important role of PARIS in PD pathogenesis, unbiased transcriptomic profiles influenced by PARIS accumulation in dopaminergic neurons remain unexplored.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We engineered Tet-Off conditional transgenic mice expressing PARIS in dopaminergic neurons, driven by DAT-PF-tTA driver mice. The conditional PARIS transgenic mice were characterized by PD-associated pathologies, including progressive dopamine cell loss, neuroinflammation, PGC-1\u03b1 repression, and mitochondrial proteome alteration. Motor impairment was assessed using pole and rotarod tests. L-DOPA and c-Abl inhibitors were administered to PARIS transgenic mice to evaluate their therapeutic efficacy. The transcriptomic profiles and gene ontology clusters were analyzed by bulk and single-nucleus RNA-seq for the ventral midbrains from PARIS transgenic and age-matched controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Conditional dopaminergic PARIS expression in mice led to the robust and selective dopaminergic neuron degeneration, neuroinflammation, and striatal dopamine deficits, resulting in L-DOPA-responsive motor impairments. Consistent with the results of previous reports, PARIS suppressed dopaminergic PGC-1\u03b1 expression, disturbed mitochondrial marker protein expression, and reduced COXIV-labeled mitochondria in dopamine neurons. Pharmacological inhibition of c-Abl activity in PARIS transgenic mice largely prevents PD-associated pathological features. Unbiased transcriptomic analysis revealed PARIS-regulated differentially expressed genes (DEGs), both collectively and in a cell-type-specific manner, along with enriched biological pathways linked to PD pathogenesis. Single-cell resolution transcriptomic analysis confirmed repression of PGC-1\u03b1 and several mitochondria-related target genes in dopaminergic cells. Additionally, we identified distinct glial cell subpopulations and DEGs associated with PD pathogenesis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Conditional PARIS transgenic mice recapitulate robust and dopaminergic neuron-selective pathological features of PD, allowing the preclinical evaluation of antisymptomatic and disease-modifying therapeutic strategies within a couple of months. Based on this new PD mouse model, we provide unbiased bulk and single-nucleus transcriptomic profiles that are regulated by PARIS and potentially contribute to PD pathogenesis. A PD mouse model with flexible pathology induction capacity and a whole transcriptome could serve as a useful resource for translational PD research.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13024-025-00814-3","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:09:47Z","timestamp":1740748187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Preclinical studies and transcriptome analysis in a model of Parkinson\u2019s disease with dopaminergic ZNF746 expression"],"prefix":"10.1186","volume":"20","author":[{"given":"Ji Hun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyojung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang-Khoa","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Joo","family":"Maeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areum","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Heon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Ho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon-Man","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gum Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Key-Hwan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valina L.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Yeol","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0182-2279","authenticated-orcid":false,"given":"Yunjong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"814_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.410270405","volume":"27","author":"GM Halliday","year":"1990","unstructured":"Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RG, Howe PR, Blessing WW, Geffen LB. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson\u2019s disease. Ann Neurol. 1990;27:373\u201385.","journal-title":"Ann Neurol"},{"key":"814_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","volume":"28","author":"DJ Moore","year":"2005","unstructured":"Moore DJ, West AB, Dawson VL, Dawson TM. Molecular pathophysiology of Parkinson\u2019s disease. Annu Rev Neurosci. 2005;28:57\u201387.","journal-title":"Annu Rev Neurosci"},{"key":"814_CR3","doi-asserted-by":"crossref","unstructured":"Lee Y, Dawson VL, Dawson TM. Animal models of Parkinson's disease: vertebrate genetics. Cold Spring Harb Perspect Med. 2012;2:a009324.","DOI":"10.1101\/cshperspect.a009324"},{"key":"814_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","volume":"12","author":"A Dovonou","year":"2023","unstructured":"Dovonou A, Bolduc C, Soto Linan V, Gora C, Peralta Iii MR, Levesque M. Animal models of Parkinson\u2019s disease: bridging the gap between disease hallmarks and research questions. Transl Neurodegener. 2023;12:36.","journal-title":"Transl Neurodegener"},{"key":"814_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392:605\u20138.","journal-title":"Nature"},{"key":"814_CR6","doi-asserted-by":"publisher","first-page":"43628","DOI":"10.1074\/jbc.M308947200","volume":"278","author":"MS Goldberg","year":"2003","unstructured":"Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni EG, Wu N, Ackerson LC, Klapstein GJ, et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem. 2003;278:43628\u201335.","journal-title":"J Biol Chem"},{"key":"814_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.neures.2007.08.005","volume":"59","author":"Y Imai","year":"2007","unstructured":"Imai Y, Inoue H, Kataoka A, Hua-Qin W, Masuda M, Ikeda T, Tsukita K, Soda M, Kodama T, Fuwa T, et al. Pael receptor is involved in dopamine metabolism in the nigrostriatal system. Neurosci Res. 2007;59:413\u201325.","journal-title":"Neurosci Res"},{"key":"814_CR8","doi-asserted-by":"crossref","unstructured":"Jo A, Lee Y, Kam TI, Kang SU, Neifert S, Karuppagounder SS, Khang R, Kang H, Park H, Chou SC, et al. PARIS farnesylation prevents neurodegeneration in models of Parkinson's disease. Sci Transl Med. 2021;13:eaax8891.","DOI":"10.1126\/scitranslmed.aax8891"},{"key":"814_CR9","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/nn.3500","volume":"16","author":"Y Lee","year":"2013","unstructured":"Lee Y, Karuppagounder SS, Shin JH, Lee YI, Ko HS, Swing D, Jiang H, Kang SU, Lee BD, Kang HC, et al. Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss. Nat Neurosci. 2013;16:1392\u2013400.","journal-title":"Nat Neurosci"},{"key":"814_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","volume":"144","author":"JH Shin","year":"2011","unstructured":"Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, Troconso JC, Dawson VL, Dawson TM. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson\u2019s disease. Cell. 2011;144:689\u2013702.","journal-title":"Cell"},{"key":"814_CR11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.celrep.2016.12.090","volume":"18","author":"Y Lee","year":"2017","unstructured":"Lee Y, Stevens DA, Kang SU, Jiang H, Lee YI, Ko HS, Scarffe LA, Umanah GE, Kang H, Ham S, et al. PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival. Cell Rep. 2017;18:918\u201332.","journal-title":"Cell Rep"},{"key":"814_CR12","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1093\/brain\/awab356","volume":"144","author":"H Kim","year":"2021","unstructured":"Kim H, Shin JY, Jo A, Kim JH, Park S, Choi JY, Kang HC, Dawson VL, Dawson TM, Shin JH, Lee Y. Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration. Brain. 2021;144:3674\u201391.","journal-title":"Brain"},{"key":"814_CR13","doi-asserted-by":"publisher","first-page":"16691","DOI":"10.1073\/pnas.1006083107","volume":"107","author":"HS Ko","year":"2010","unstructured":"Ko HS, Lee Y, Shin JH, Karuppagounder SS, Gadad BS, Koleske AJ, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin\u2019s ubiquitination and protective function. Proc Natl Acad Sci U S A. 2010;107:16691\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"814_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1523\/JNEUROSCI.1833-10.2011","volume":"31","author":"SZ Imam","year":"2011","unstructured":"Imam SZ, Zhou Q, Yamamoto A, Valente AJ, Ali SF, Bains M, Roberts JL, Kahle PJ, Clark RA, Li S. Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson\u2019s disease. J Neurosci. 2011;31:157\u201363.","journal-title":"J Neurosci"},{"key":"814_CR15","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/hmg\/ddt674","volume":"23","author":"AL Mahul-Mellier","year":"2014","unstructured":"Mahul-Mellier AL, Fauvet B, Gysbers A, Dikiy I, Oueslati A, Georgeon S, Lamontanara AJ, Bisquertt A, Eliezer D, Masliah E, et al. c-Abl phosphorylates alpha-synuclein and regulates its degradation: implication for alpha-synuclein clearance and contribution to the pathogenesis of Parkinson\u2019s disease. Hum Mol Genet. 2014;23:2858\u201379.","journal-title":"Hum Mol Genet"},{"key":"814_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3233\/JPD-171191","volume":"7","author":"S Brahmachari","year":"2017","unstructured":"Brahmachari S, Karuppagounder SS, Ge P, Lee S, Dawson VL, Dawson TM, Ko HS. c-Abl and Parkinson\u2019s Disease: Mechanisms and Therapeutic Potential. J Parkinsons Dis. 2017;7:589\u2013601.","journal-title":"J Parkinsons Dis"},{"key":"814_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13024-020-00364-w","volume":"15","author":"MR Karim","year":"2020","unstructured":"Karim MR, Liao EE, Kim J, Meints J, Martinez HM, Pletnikova O, Troncoso JC, Lee MK. alpha-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment. Mol Neurodegener. 2020;15:27.","journal-title":"Mol Neurodegener"},{"key":"814_CR18","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1172\/JCI85456","volume":"126","author":"S Brahmachari","year":"2016","unstructured":"Brahmachari S, Ge P, Lee SH, Kim D, Karuppagounder SS, Kumar M, Mao X, Shin JH, Lee Y, Pletnikova O, et al. Activation of tyrosine kinase c-Abl contributes to alpha-synuclein-induced neurodegeneration. J Clin Invest. 2016;126:2970\u201388.","journal-title":"J Clin Invest"},{"key":"814_CR19","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1038\/srep04874","volume":"4","author":"SS Karuppagounder","year":"2014","unstructured":"Karuppagounder SS, Brahmachari S, Lee Y, Dawson VL, Dawson TM, Ko HS. The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson\u2019s disease. Sci Rep. 2014;4:4874.","journal-title":"Sci Rep"},{"key":"814_CR20","doi-asserted-by":"publisher","first-page":"eabp9352","DOI":"10.1126\/scitranslmed.abp9352","volume":"15","author":"SS Karuppagounder","year":"2023","unstructured":"Karuppagounder SS, Wang H, Kelly T, Rush R, Nguyen R, Bisen S, Yamashita Y, Sloan N, Dang B, Sigmon A, et al. The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson\u2019s disease. Sci Transl Med. 2023;15:eabp9352.","journal-title":"Sci Transl Med."},{"key":"814_CR21","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1093\/brain\/awz172","volume":"142","author":"S Brahmachari","year":"2019","unstructured":"Brahmachari S, Lee S, Kim S, Yuan C, Karuppagounder SS, Ge P, Shi R, Kim EJ, Liu A, Kim D, et al. Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson\u2019s disease. Brain. 2019;142:2380\u2013401.","journal-title":"Brain"},{"key":"814_CR22","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1523\/JNEUROSCI.0089-14.2015","volume":"35","author":"L Chen","year":"2015","unstructured":"Chen L, Xie Z, Turkson S, Zhuang X. A53T human alpha-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration. J Neurosci. 2015;35:890\u2013905.","journal-title":"J Neurosci"},{"key":"814_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archneur.56.5.529","volume":"56","author":"S Fahn","year":"1999","unstructured":"Fahn S. Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA Arch Neurol. 1999;56:529\u201335.","journal-title":"Earlier vs Later L-DOPA Arch Neurol"},{"key":"814_CR24","doi-asserted-by":"publisher","first-page":"11696","DOI":"10.1073\/pnas.1500624112","volume":"112","author":"DA Stevens","year":"2015","unstructured":"Stevens DA, Lee Y, Kang HC, Lee BD, Lee YI, Bower A, Jiang H, Kang SU, Andrabi SA, Dawson VL, et al. Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration. Proc Natl Acad Sci U S A. 2015;112:11696\u2013701.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"814_CR25","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"DJ Surmeier","year":"2018","unstructured":"Surmeier DJ. Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J. 2018;285:3657\u201368.","journal-title":"FEBS J"},{"key":"814_CR26","doi-asserted-by":"crossref","unstructured":"Bohush A, Niewiadomska G, Filipek A. Role of Mitogen Activated Protein Kinase Signaling in Parkinson's Disease. Int J Mol Sci 2018;19:2973.","DOI":"10.3390\/ijms19102973"},{"key":"814_CR27","doi-asserted-by":"crossref","unstructured":"Walker CL, Liu NK, Xu XM. PTEN\/PI3K and MAPK signaling in protection and pathology following CNS injuries. Front Biol (Beijing). 2013;8:421\u201333.","DOI":"10.1007\/s11515-013-1255-1"},{"key":"814_CR28","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1126\/science.286.5443.1358","volume":"286","author":"A Bonni","year":"1999","unstructured":"Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 1999;286:1358\u201362.","journal-title":"Science"},{"key":"814_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.814889","volume":"13","author":"DS Bouvier","year":"2022","unstructured":"Bouvier DS, Fixemer S, Heurtaux T, Jeannelle F, Frauenknecht KBM, Mittelbronn M. The Multifaceted Neurotoxicity of Astrocytes in Ageing and Age-Related Neurodegenerative Diseases: A Translational Perspective. Front Physiol. 2022;13: 814889.","journal-title":"Front Physiol"},{"key":"814_CR30","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1134\/S0006297922090012","volume":"87","author":"YV Gorina","year":"2022","unstructured":"Gorina YV, Salmina AB, Erofeev AI, Gerasimov EI, Bolshakova AV, Balaban PM, Bezprozvanny IB, Vlasova OL. Astrocyte Activation Markers. Biochemistry (Mosc). 2022;87:851\u201370.","journal-title":"Biochemistry (Mosc)"},{"key":"814_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuroscience.2014.11.018","volume":"302","author":"MS Moehle","year":"2015","unstructured":"Moehle MS, West AB. M1 and M2 immune activation in Parkinson\u2019s Disease: Foe and ally? Neuroscience. 2015;302:59\u201373.","journal-title":"Neuroscience"},{"key":"814_CR32","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","volume":"2","author":"J Bove","year":"2005","unstructured":"Bove J, Prou D, Perier C, Przedborski S. Toxin-induced models of Parkinson\u2019s disease. NeuroRx. 2005;2:484\u201394.","journal-title":"NeuroRx"},{"key":"814_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106362","volume":"9","author":"M Asanuma","year":"2014","unstructured":"Asanuma M, Miyazaki I, Murakami S, Diaz-Corrales FJ, Ogawa N. Striatal astrocytes act as a reservoir for L-DOPA. PLoS ONE. 2014;9: e106362.","journal-title":"PLoS ONE"},{"key":"814_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2021.102070","volume":"202","author":"S Ghosh","year":"2021","unstructured":"Ghosh S, Won SJ, Wang J, Fong R, Butler NJM, Moss A, Wong C, Pan J, Sanchez J, Huynh A, et al. alpha-synuclein aggregates induce c-Abl activation and dopaminergic neuronal loss by a feed-forward redox stress mechanism. Prog Neurobiol. 2021;202: 102070.","journal-title":"Prog Neurobiol"},{"key":"814_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1212\/WNL.44.3_Part_1.437","volume":"44","author":"H Takahashi","year":"1994","unstructured":"Takahashi H, Ohama E, Suzuki S, Horikawa Y, Ishikawa A, Morita T, Tsuji S, Ikuta F. Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology. 1994;44:437\u201341.","journal-title":"Neurology"},{"key":"814_CR36","doi-asserted-by":"crossref","unstructured":"Ham S, Yun SP, Kim H, Kim D, Seo BA, Kim H, Shin JY, Dar MA, Lee GH, Lee YI, et al. Amyloid-like oligomerization of AIMP2 contributes to alpha-synuclein interaction and Lewy-like inclusion. Sci Transl Med. 2020;12:eaax0091.","DOI":"10.1126\/scitranslmed.aax0091"},{"key":"814_CR37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature11740","volume":"493","author":"KM Tye","year":"2013","unstructured":"Tye KM, Mirzabekov JJ, Warden MR, Ferenczi EA, Tsai HC, Finkelstein J, Kim SY, Adhikari A, Thompson KR, Andalman AS, et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature. 2013;493:537\u201341.","journal-title":"Nature"},{"key":"814_CR38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fnbeh.2014.00290","volume":"8","author":"A Bonito-Oliva","year":"2014","unstructured":"Bonito-Oliva A, Masini D, Fisone G. A mouse model of non-motor symptoms in Parkinson\u2019s disease: focus on pharmacological interventions targeting affective dysfunctions. Front Behav Neurosci. 2014;8:290.","journal-title":"Front Behav Neurosci"},{"key":"814_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025346","volume":"6","author":"TW Kim","year":"2011","unstructured":"Kim TW, Moon Y, Kim K, Lee JE, Koh HC, Rhyu IJ, Kim H, Sun W. Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson\u2019s diseases. PLoS ONE. 2011;6: e25346.","journal-title":"PLoS ONE"},{"key":"814_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","volume":"5","author":"SL Alberico","year":"2015","unstructured":"Alberico SL, Cassell MD, Narayanan NS. The Vulnerable Ventral Tegmental Area in Parkinson\u2019s Disease. Basal Ganglia. 2015;5:51\u20135.","journal-title":"Basal Ganglia"},{"key":"814_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/npp.2009.83","volume":"35","author":"LM Shin","year":"2010","unstructured":"Shin LM, Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology. 2010;35:169\u201391.","journal-title":"Neuropsychopharmacology"},{"key":"814_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.12740\/PP\/OnlineFirst\/152782","volume":"58","author":"K Gibek","year":"2024","unstructured":"Gibek K, Sacha T, Cyranka K. Side effects of treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia and the occurrence of anxiety symptoms. Psychiatr Pol. 2024;58:25\u201338.","journal-title":"Psychiatr Pol"},{"key":"814_CR43","first-page":"277","volume":"27","author":"K Gibek","year":"2023","unstructured":"Gibek K. Side effects of treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukaemia and the occurrence of depressive symptoms. Contemp Oncol (Pozn). 2023;27:277\u201383.","journal-title":"Contemp Oncol (Pozn)"},{"key":"814_CR44","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2014;29:1583\u201390.","journal-title":"Mov Disord"},{"key":"814_CR45","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/jnnp-2015-312283","volume":"87","author":"F Moisan","year":"2016","unstructured":"Moisan F, Kab S, Mohamed F, Canonico M, Le Guern M, Quintin C, Carcaillon L, Nicolau J, Duport N, Singh-Manoux A, et al. Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J Neurol Neurosurg Psychiatry. 2016;87:952\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"814_CR46","doi-asserted-by":"publisher","first-page":"884S","DOI":"10.3945\/ajcn.110.001917","volume":"93","author":"PJ Fernandez-Marcos","year":"2011","unstructured":"Fernandez-Marcos PJ, Auwerx J. Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr. 2011;93:884S \u2013 890.","journal-title":"Am J Clin Nutr"},{"key":"814_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 1999;98:115\u201324.","journal-title":"Cell"},{"key":"814_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12920-016-0164-y","volume":"9","author":"A Dumitriu","year":"2016","unstructured":"Dumitriu A, Golji J, Labadorf AT, Gao B, Beach TG, Myers RH, Longo KA, Latourelle JC. Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease. BMC Med Genomics. 2016;9:5.","journal-title":"BMC Med Genomics"},{"key":"814_CR49","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun SP, Kam TI, Panicker N, Kim S, Oh Y, Park JS, Kwon SH, Park YJ, Karuppagounder SS, Park H, et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat Med. 2018;24:931\u20138.","journal-title":"Nat Med"},{"key":"814_CR50","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1468-1331.2009.02900.x","volume":"17","author":"P Barone","year":"2010","unstructured":"Barone P. Neurotransmission in Parkinson\u2019s disease: beyond dopamine. Eur J Neurol. 2010;17:364\u201376.","journal-title":"Eur J Neurol"},{"key":"814_CR51","doi-asserted-by":"publisher","unstructured":"Luong TN, Carlisle HJ, Southwell A, Patterson PH. Assessment of motor balance and coordination in mice using the balance beam. J Vis Exp. 2011;(49):e2376. https:\/\/doi.org\/10.3791\/2376.","DOI":"10.3791\/2376"},{"key":"814_CR52","doi-asserted-by":"crossref","unstructured":"Can A, Dao DT, Terrillion CE, Piantadosi SC, Bhat S, Gould TD. The tail suspension test. J Vis Exp. 2012;(59):e3769.","DOI":"10.3791\/3769-v"},{"key":"814_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2019.121805","volume":"1129","author":"S Yu","year":"2019","unstructured":"Yu S, Yin Y, Li Q, Yu J, Liu W, Wang D, Cheng Q, Xie S, Cheng X, Qiu L. Validation of an improved liquid chromatography tandem mass spectrometry method for rapid and simultaneous analysis of plasma catecholamine and their metabolites. J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1129: 121805.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"814_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4626","volume":"33","author":"Z Lin","year":"2019","unstructured":"Lin Z, Wang H, Hu L, Li J, Lin J, Liu B, Zhao Z, Rao Y. Simultaneous determination of N-ethylpentylone, dopamine, 5-hydroxytryptamine and their metabolites in rat brain microdialysis by liquid chromatography tandem mass spectrometry. Biomed Chromatogr. 2019;33: e4626.","journal-title":"Biomed Chromatogr"},{"key":"814_CR55","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2116\/analsci.20P429","volume":"37","author":"S Koike","year":"2021","unstructured":"Koike S, Miyaji Y, Sano H, Aikawa N, Kai M, Kasahara S, Suzuki T, Nishimoto-Kusunose S, Ogasawara Y. Simultaneous Determination of Five Bile Acids as Potential Biomarkers for Alzheimer\u2019s Disease in Mouse Brain and Plasma. Anal Sci. 2021;37:1165\u201370.","journal-title":"Anal Sci"},{"key":"814_CR56","doi-asserted-by":"publisher","first-page":"7799","DOI":"10.1007\/s00216-014-8230-9","volume":"406","author":"SE Jantti","year":"2014","unstructured":"Jantti SE, Kivilompolo M, Ohrnberg L, Pietilainen KH, Nygren H, Oresic M, Hyotylainen T. Quantitative profiling of bile acids in blood, adipose tissue, intestine, and gall bladder samples using ultra high performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2014;406:7799\u2013815.","journal-title":"Anal Bioanal Chem"},{"key":"814_CR57","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1002\/jssc.201100436","volume":"34","author":"I Surowiec","year":"2011","unstructured":"Surowiec I, Koc M, Antti H, Wikstrom P, Moritz T. LC-MS\/MS profiling for detection of endogenous steroids and prostaglandins in tissue samples. J Sep Sci. 2011;34:2650\u20138.","journal-title":"J Sep Sci"},{"key":"814_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2022.114886","volume":"219","author":"Z Lu","year":"2022","unstructured":"Lu Z, Li S, Aa N, Zhang Y, Zhang R, Xu C, Zhang S, Kong X, Wang G, Aa J, Zhang Y. Quantitative analysis of 20 purine and pyrimidine metabolites by HILIC-MS\/MS in the serum and hippocampus of depressed mice. J Pharm Biomed Anal. 2022;219: 114886.","journal-title":"J Pharm Biomed Anal"},{"key":"814_CR59","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s40005-022-00563-1","volume":"52","author":"DK Vo","year":"2022","unstructured":"Vo DK, Nguyen TT, Maeng HJ. Effects of 1alpha,25-dihydroxyvitamin D(3) on the pharmacokinetics and biodistribution of ergothioneine, an endogenous organic cation\/carnitine transporter 1 substrate, in rats. J Pharm Investig. 2022;52:341\u201351.","journal-title":"J Pharm Investig"},{"key":"814_CR60","doi-asserted-by":"crossref","unstructured":"Oh S, Abdelnabi J, Al-Dulaimi R, Aggarwal A, Ramos M, Davis S, Riester M, Waldron L: HGNChelper: identification and correction of invalid gene symbols for human and mouse. F1000Res. 2020:9:1493.","DOI":"10.12688\/f1000research.28033.1"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00814-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00814-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00814-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:54:33Z","timestamp":1740750873000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00814-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["814"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00814-3","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"8 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}